Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease

被引:83
作者
Davies, M
Heys, SE
Selby, PL
Berry, JL
Mawer, EB
机构
[1] Bone Disease Research Centre, University Department of Medicine, Manchester Royal Infirmary, Manchester
[2] University Department of Medicine, Manchester Royal Infirmary, Manchester
关键词
D O I
10.1210/jc.82.1.209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serum vitamin D metabolites and PTH were measured in seven subjects with a history of previous partial gastrectomy (PGX) and metabolic bone disease. The elimination t 1/2 of [H-3]25-hydroxyvitamin D-3 ([H-3]25OHD(3)) in serum was assessed after an iv pulse dose of 5 mu Ci [26,27-H-3]25OHD(3). Median serum 25OHD(3) was 37.5 (27.5-101.3) nmol/L, [normal range (NR) 10.8-58.5 nmol/L], mean serum 1,25-dihydroxyvitamin D [1,25-(OH)(2)D-3] was raised at 175 +/- 72 pmol/L, (NR 48-120 pmol/L) and mean PTH was also high, 67 +/- 27 ng/L, (NR 10-60 ng/L). Serum t 1/2 [H-3]250HD(3) ranged from 10.9-21.2; days. A strong negative correlation existed between t 1/2 [H-3]250HD(3) and serum 1,25-(OH)(2)D-3 [Spearman's rank correlation coefficient (r = -0.82, P = 0.002)] and PTH [Spearman's rank correlation coefficient (r = -0.81, P = 0.001)]. Four subjects who had high initial PTH concentrations (60-115 ng/L) and elevated 1,25-(OH)(2)D levels (162-300 pmol/L) were reassessed after calcium supplementation to suppress secondary hyperparathyroidism (2 degrees HPT). In this subgroup, after-treatment PTH fell from 82 +/- 24 to 52 +/- 24 ng/L (mean +/- SD), not significant; 1,25-(OH)(2)D fell from 210 +/- 61 to 116 +/- 28 pmol/L, P = 0.015; and t 1/2 [H-3]25OHD(3) increased from 13.2 +/- 1.9 to 18.9 +/- 3.1 days, P = 0.012. Patients with PGX and evidence of 2 degrees HPT with elevated 1,25-(OH)(2)D have a reduced t 1/2 [H-3]25OHD(3), and this may explain the increased susceptibility of the subjects to osteomalacia. Calcium supplementation suppresses 2 degrees HPT, increases t 1/2 [H-3]25OHD(3) and may protect against PGX osteoporosis and osteomalacia.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 24 条
  • [2] METABOLISM OF VITAMIN D3-3H IN HUMAN SUBJECTS - DISTRIBUTION IN BLOOD BILE FECES AND URINE
    AVIOLI, LV
    LEE, SW
    MCDONALD, JE
    LUND, J
    DELUCA, HF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1967, 46 (06) : 983 - &
  • [3] METABOLISM OF 25-HYDROXYVITAMIN-D3 IN RATS - LOW-CALCIUM DIET VS CALCITRIOL INFUSION
    BOLT, MJG
    JENSEN, WE
    SITRIN, MD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03): : E359 - E367
  • [4] THE ROLE OF 1,25-DIHYDROXYVITAMIN-D IN THE MECHANISM OF ACQUIRED VITAMIN-D DEFICIENCY
    CLEMENTS, MR
    DAVIES, M
    HAYES, ME
    HICKEY, CD
    LUMB, GA
    MAWER, EB
    ADAMS, PH
    [J]. CLINICAL ENDOCRINOLOGY, 1992, 37 (01) : 17 - 27
  • [5] A NEW MECHANISM FOR INDUCED VITAMIN-D DEFICIENCY IN CALCIUM DEPRIVATION
    CLEMENTS, MR
    JOHNSON, L
    FRASER, DR
    [J]. NATURE, 1987, 325 (6099) : 62 - 65
  • [6] METABOLIC INACTIVATION OF VITAMIN-D IS ENHANCED IN PRIMARY HYPERPARATHYROIDISM
    CLEMENTS, MR
    DAVIES, M
    FRASER, DR
    LUMB, GA
    MAWER, EB
    ADAMS, PH
    [J]. CLINICAL SCIENCE, 1987, 73 (06) : 659 - 664
  • [7] COMPARATIVE ABSORPTION OF VITAMIN-D3 AND 25-HYDROXYVITAMIN D3 IN INTESTINAL DISEASE
    DAVIES, M
    MAWER, EB
    KRAWITT, EL
    [J]. GUT, 1980, 21 (04) : 287 - 292
  • [8] A 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR-LIKE PROTEIN IN MAMMALIAN AND AVIAN LIVER NUCLEI
    DUNCAN, WE
    WHITEHEAD, D
    WRAY, HL
    [J]. ENDOCRINOLOGY, 1988, 122 (06) : 2584 - 2589
  • [9] METABOLIC BONE DISEASE AFTER GASTRECTOMY
    EDDY, RL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1971, 50 (04) : 442 - &
  • [10] FOX J, 1990, AM J PHYSIOL, V258, pE828